preced
concurr
viral
respiratori
tract
infect
predispos
secondari
bacteri
coinfect
throughout
airway
mechan
virus
promot
superinfect
divers
replet
wherea
understand
much
virus
damag
airway
dysregul
innat
acquir
immun
respons
turn
support
bacteri
growth
adher
invas
normal
steril
site
within
respiratori
tract
new
inform
regard
coinfect
gain
recent
advanc
microbiom
research
enhanc
appreci
contribut
bacteri
biofilm
among
other
advanc
understand
obtain
continu
research
effort
aspect
viralbacteri
coinfect
respiratori
tract
allow
us
devis
novel
approach
diseas
prevent
well
develop
effect
therapeut
healthi
person
season
influenza
usual
resolv
without
consequ
howev
year
approxim
hospit
death
occur
us
alon
greatest
risk
secondari
bacteri
pneumonia
children
age
adult
pregnant
women
individu
age
comorbid
ill
longstand
evid
role
influenza
viru
bacteri
pneumonia
deriv
studi
four
welldocu
pandem
last
year
wherea
streptococcu
pneumonia
spn
predomin
bacteri
pathogen
associ
pandem
staphylococcu
aureu
account
death
recent
pandem
interestingli
major
death
person
streptococcu
pyogen
haemophilu
influenza
gram
neg
rod
identifi
caus
agent
addit
spn
aureu
despit
introduct
antibiot
influenza
vaccin
period
pandem
death
secondari
bacteri
pneumonia
remain
signific
problem
fact
part
due
rapid
age
us
popul
associ
mortal
increas
multipl
addit
infect
airway
predic
bacteri
superinfect
either
subsequ
concurr
ongo
upper
respiratori
tract
urt
viral
infect
due
influenza
influenza
b
respiratori
syncyti
viru
rsv
rhinoviru
rv
human
coronaviru
parainfluenza
viru
adenoviru
av
among
other
viral
cold
predispos
bacteri
rhinosinus
adult
children
among
common
infect
seen
primari
care
one
prospect
longitudin
studi
children
viral
urti
complic
acut
bacteri
rhinosinus
spn
h
influenza
moraxella
catarrhali
staphylococci
respiratori
anaerob
predomin
acut
chronic
rhinosinus
otiti
media
middl
ear
infect
virtual
urt
viru
well
enterovirus
predispos
middl
ear
invas
bacteria
normal
resid
nasopharynx
np
predomin
bacteri
pathogen
om
spn
nontyp
h
influenza
catarrhali
wherea
urt
virus
uniqu
term
specif
histopatholog
natur
evok
immun
respons
net
effect
viral
infect
lead
om
compromis
protect
function
eustachian
tube
thu
bounti
evid
support
parent
lore
kid
get
cold
week
later
ear
infect
posit
associ
viral
rti
bacteri
superinfect
also
demonstr
rhiniti
rsvinduc
bronchiol
acut
expiratori
wheez
cystic
fibrosi
autosom
inherit
diseas
affect
person
worldwid
character
recurr
chronic
rti
exacerb
infect
common
respiratori
tract
virus
pseudomona
aeruginosa
aureu
predomin
caus
agent
exacerb
viral
bacteri
infect
also
associ
exacerb
chronic
obstruct
pulmonari
diseas
copd
copd
expect
rank
third
lead
caus
death
worldwid
http
wide
varieti
urt
virus
implic
play
role
bacteri
exacerb
copd
due
usual
suspect
h
influenza
spn
catarrhali
aureu
p
aeruginosa
enterobact
spp
support
recent
studi
found
day
experiment
rv
infect
subject
copd
sixfold
increas
copi
number
rise
number
proteobacteri
sequenc
detect
sputum
compar
baselin
valu
obtain
sputum
collect
rv
inocul
h
influenza
predomin
much
learn
date
glean
anim
model
shown
complex
molecular
mechan
underli
abil
virus
predispos
bacteri
superinfect
see
tabl
detail
descript
reader
refer
sever
review
briefli
howev
gener
outcom
viral
infect
induc
destruct
airway
histolog
function
depend
viru
histopatholog
induc
rel
mild
sever
includ
evid
cell
loss
goblet
cell
hyperplasia
alter
mucu
secret
andor
biochemistri
disrupt
surfact
reduc
ciliari
beat
frequenc
discoordin
mucociliari
clearanc
function
reduc
oxygen
exchang
effect
long
associ
potenti
mechan
virus
predispos
respiratori
tract
bacteri
superinfect
addit
specif
mechan
associ
viralbacteri
coinfect
discuss
greater
detail
depend
viru
bacteri
speciesstrain
experiment
system
use
viral
infect
shown
promot
bacteri
adher
airway
colon
via
number
mechan
use
ferret
model
peltola
et
al
report
influenza
virus
subtyp
increas
colon
np
spn
howev
specif
subtyp
associ
develop
bacteri
sinus
om
find
contribut
understand
bacteri
complic
rate
greater
season
particular
influenza
subtyp
predomin
mechan
influenza
viral
neuraminidas
shown
expos
host
cell
receptor
use
bacteria
adher
due
sialidas
activ
alter
epitheli
cell
surfac
carbohydr
moieti
also
known
enhanc
bacteri
adher
via
activ
tgfb
induc
upregul
express
fibronectin
integrin
bacteria
bind
moreov
stimul
type
interferon
ifn
influenza
viru
lead
decreas
product
chemokin
result
impair
recruit
macrophag
requir
pneumococc
clearanc
therebi
promot
spn
colon
mice
influenza
viru
also
prime
mice
pneumonia
due
aureu
bacteri
viral
titer
enhanc
coinfect
investig
latter
studi
hypothes
viral
titer
increas
bacteri
coinfect
due
enhanc
viru
releas
infect
cell
bacteri
titer
increas
due
alveolar
macrophag
impair
urt
virus
also
enhanc
bacteri
adher
primari
immort
epitheli
cell
distinct
differ
note
amongst
epitheli
cell
type
term
respons
infect
rsv
parainfluenza
influenza
viru
novotni
bakaletz
recent
show
rsv
av
induc
upregul
express
cell
surfac
glycoprotein
intercellular
adhes
molecul
primari
respiratori
tract
epitheli
cell
serv
cognat
ligand
type
iv
pilu
nontyp
h
influenza
thu
promot
adher
gram
neg
pathogen
rsv
infect
also
enhanc
adher
p
aeruginosa
normal
cf
epitheli
cell
effect
extend
gram
posit
viralbacteri
superinfect
airway
bakaletz
tabl
mechan
virus
predispos
secondari
bacteri
infect
damag
airway
epitheliuminduct
hyperplasiacel
lossexposur
basement
membran
diminish
ciliari
beat
frequencydisrupt
mucociliari
clearancealt
mucu
rheolog
increas
receptor
avail
epitheli
cell
promot
augment
bacteri
adher
dysregul
activ
migrat
function
antigen
present
cell
alveolar
macrophag
dendrit
cell
tissu
resid
macrophag
tcell
disrupt
phagocyt
function
abnorm
express
antimicrobialhost
defens
peptid
virusinduc
type
interferon
alter
phenotyp
immun
respons
enhanc
product
inflammatori
mediat
cytokin
chemokin
acut
phase
reactant
gener
immunosuppress
lead
immun
paralysi
virusmedi
releas
bacteria
biofilm
viral
dysregul
nutrit
immun
viru
induc
alter
microbiom
increas
pathogen
associ
secondari
infect
bacteria
rsv
infect
spn
serotyp
test
show
signific
increas
adher
two
cell
line
similarli
children
load
spn
np
increas
coincid
commun
acquir
pneumonia
infect
either
rsv
rv
high
np
colon
densiti
spn
also
observ
adult
viral
urti
hiv
infect
viralbacteri
coinfect
subvert
mani
aspect
mucos
immun
net
result
failur
control
bacteri
replic
complex
field
far
beyond
scope
brief
review
reader
direct
sever
excel
comprehens
review
howev
sever
main
conclus
field
discuss
includ
effect
viral
infect
phagocyt
function
influenza
viru
induc
deplet
am
via
promot
apoptosi
wellknown
facilit
bacteri
superinfect
via
track
dyelabel
am
murin
model
investig
show
resid
am
lost
first
week
influenza
remain
cell
demonstr
necrot
phenotyp
wherea
initi
bacteri
challeng
dose
clear
within
three
hour
noninfluenza
infect
mice
influenza
coinfect
bacteri
inoculum
remain
recover
time
point
addit
reduct
cell
number
via
deplet
phagocyt
function
also
affect
viral
infect
influenza
viru
infect
am
result
low
level
product
cytokin
chemokin
necessari
recruit
activ
neutrophil
suppress
nadph
oxidasedepend
phagocyt
bacteri
clearanc
therebi
enhanc
suscept
secondari
bacteri
infect
mention
viru
infect
induc
dysregul
proinflammatori
cytokin
respons
includ
limit
induc
influenza
viru
gener
believ
play
major
role
predispos
secondari
bacteri
infect
wherea
type
ifn
wellcharacter
antivir
immunostimulatori
properti
ifn
product
mistim
inappropri
andor
excess
detriment
effect
key
observ
includ
role
ifn
promot
product
specif
cytokin
immunosuppress
proinflammatori
suppress
cytokin
key
linkag
innat
adapt
immun
respons
includ
reduc
function
dendrit
cell
macrophag
natur
killer
cell
tcell
lead
impair
abil
effect
erad
bacteri
copathogen
also
phagocyt
independ
mechan
viru
infect
predispos
secondari
bacteri
infect
express
antimicrobi
host
defens
peptid
camp
among
other
dysregul
urt
virus
chinchilla
model
rsv
infect
reduc
transcript
abund
chinchilla
betadefensin
ortholog
human
bdefensin
concurr
rsv
infect
induc
increas
np
load
nontyp
h
influenza
deliveri
intranas
inactiv
avail
local
either
recombin
augment
avail
host
defens
peptid
demonstr
disrupt
avail
even
singl
innat
immun
effector
due
viral
infect
signific
impact
rel
load
h
influenza
within
airway
wherea
bacteri
superinfect
associ
gener
immunosuppress
virus
eg
hiv
cmv
measl
viru
mev
among
other
restrict
respiratori
tract
role
virus
need
consid
prior
use
combin
antiretrovir
therapi
pneumocysti
pneumonia
preval
hivassoci
pulmonari
diseas
howev
sinc
broad
use
potent
drug
combin
high
incom
countri
chang
commun
acquir
bacteri
pneumonia
low
incom
countri
tuberculosi
tb
prevail
hallmark
hiv
infect
sever
deplet
cell
contribut
fact
person
live
hiv
time
like
develop
tb
without
hiv
hiv
viru
also
report
facilit
infect
mycobacterium
tuberculosi
varieti
effect
macrophag
function
includ
upregul
express
mycobacterium
entri
receptor
manipul
macrophag
bactericid
pathway
alter
chemotaxi
induct
immun
respons
result
imbal
impair
tumor
necrosi
factormedi
apoptot
respons
inhibit
bacteri
clearanc
similarli
cytomegaloviru
cmv
infect
associ
immun
system
paralysi
character
increas
nfkb
product
lymphopenia
affect
natur
killer
cell
specif
deplet
ifng
produc
tcell
earli
infect
dysregul
cytokin
product
result
increas
tissu
damag
may
enhanc
suscept
secondari
bacteri
infect
mev
anoth
result
gener
immunosuppress
sever
case
predispos
bacteri
pneumonia
due
abil
infect
slamposit
lymphocyt
dendrit
cell
induc
tcell
apoptosi
alter
lymphocyt
traffick
suppress
prolifer
lymphocyt
result
cytokin
imbal
increas
level
suppress
level
latter
associ
prolong
immun
respons
lead
suppress
cellular
immun
better
understand
mechan
respons
intermitt
exacerb
diseas
observ
patient
cf
rv
found
induc
h
via
action
dual
oxidas
primari
cf
airway
cell
releas
h
suffici
dispers
plankton
bacteria
biofilm
form
cell
mucoid
p
aeruginosa
similarli
influenza
viru
mediat
releas
pneumococci
biofilm
intriguingli
dispers
manner
pneumococc
transcriptom
undergo
tremend
complex
chang
newli
releas
bacteria
demonstr
virul
phenotyp
releas
bacteria
capabl
reiniti
infect
within
respiratori
tract
nutrit
immun
defin
host
sequestr
trace
miner
growth
factor
need
bacteria
effort
limit
pathogen
howev
influenza
viru
subvert
defens
promot
pneumococc
growth
coinfect
provid
host
sialyl
substrat
bacteri
nutrient
sourc
via
desialyl
host
glycoconjug
similarli
hendrick
et
al
show
viral
rti
induct
antivir
interferon
promot
robust
biofilm
format
p
aeruginosa
via
mechan
dysregul
iron
homeostasi
rsvinfect
cell
increas
apic
releas
host
ironbind
protein
transferrin
util
p
aeruginosa
induc
biofilm
format
microb
latter
observ
suggest
like
mechan
clinic
observ
link
urt
viru
infect
enhanc
p
aeruginosa
colon
chronic
diseas
cf
copd
composit
microbiom
respiratori
tract
enrich
pathogen
associ
secondari
bacteri
infect
viral
rti
evalu
cohort
children
age
month
prospect
determin
chang
np
microbiom
coincid
viral
uri
pettigrew
et
al
report
shift
complex
competit
relationship
posit
neg
amongst
resid
bacteria
studi
np
bacteria
respiratori
virus
symptomat
children
without
acut
om
ruohola
et
al
found
colon
np
spn
h
influenza
increas
risk
acut
om
either
presenc
catarrhali
np
rsv
infect
increas
risk
evid
superinfect
wherein
bacteria
augment
viral
infect
airway
wherea
typic
think
viral
urt
infect
predispos
bacteri
superinfect
recent
learn
preexist
bacteri
infect
promot
viral
shed
exampl
spn
shown
augment
human
rsv
infect
vitro
vivo
studi
three
pneumococc
strain
enhanc
rsv
infect
primari
normal
human
bronchial
epitheli
cell
nasal
colon
cotton
rat
follow
three
day
later
intranas
challeng
rsv
result
strainspecif
enhanc
rsv
replic
vivo
addit
h
influenza
increas
suscept
inflammatori
respons
airway
epitheli
cell
viral
infect
via
abil
enhanc
express
turn
use
rv
attach
opportun
develop
novel
treatment
andor
prevent
strategi
gain
increas
understand
molecular
mechan
underli
viralbacteri
superinfect
improv
knowledg
provid
opportun
develop
novel
treatment
modal
prevent
strategi
wherea
viral
vaccin
develop
present
formid
obstacl
vaccin
virus
associ
increas
risk
secondari
bacteri
infect
believ
ideal
strategi
mitig
risk
addit
prevent
earli
antivir
therapi
agent
rimantadin
zanamivir
oseltamivir
propos
sever
viralbacteri
coinfect
also
interest
attempt
abrog
overli
robust
host
inflammatori
respons
commonli
elicit
viralbacteri
coinfect
wherein
control
bacteri
replic
quiet
host
immun
respons
suggest
improv
treatment
strategi
use
coinfect
mous
model
influenza
viru
legionella
pneumophila
separ
resist
pathogen
detect
elimin
toler
host
adapt
given
level
pathogen
burden
jamieson
et
al
demonstr
influenza
promot
suscept
lethal
bacteri
coinfect
even
bacteri
speci
control
host
immun
system
suggest
due
host
inabl
toler
tissu
damag
lung
damjanov
et
al
show
combin
treatment
azithromycin
dexamethasom
best
improv
clinic
outcom
bacteri
clearanc
cytokin
repons
immunopatholog
murin
model
dual
infect
ultim
goal
research
field
viralbacteri
coinfect
upper
lower
respiratori
tract
translat
improv
understand
molecular
mechan
underli
superinfect
develop
better
diagnost
treatment
modal
prevent
strategi
particularli
import
anticip
potenti
futur
pandem
emerg
novel
virus
expans
antibiot
resist
bacteri
pathogen
consid
impact
global
travel
rel
eas
transmiss
